HOME ABOUT CONTACT AVAILABLE ISSUES SUBSCRIBE MEDIA & ADS
LATEST UPDATES » Vol 25, No. 01, January 2021 – Home-Based Diagnostic Testing: Revolutionizing IBD Treatment       » Study Reveals Understanding of China’s Carbon Emission Balance       » Developing Nanomaterials for Better Performance       » Helping Farmers Monitor Plant Health and Improve Crop Yield       » Protecting the Brain through Gut-Trained Immune Cells       » Using Machine Learning to Predict Anti-Cancer Drug Efficacy      
Vol 21, No. 06, June 2017   |   Issue PDF view/purchase
EDITOR'S LETTER
Rare diseases are more common than you think. Some of these are genetic-related such as haemophilia, Pompe disease, and muscular dystrophy, to name a few. Early intervention is important for rare disease patients but sadly, many affected are still facing the difficulty of getting accurate diagnosis timely. Yet, only 5% of 7,000 rare diseases have treatment approved by FDA.

Shire is one of the companies in Asia Pacific that provides therapies for patients with rare and threatening diseases, supporting campaigns to improve diagnosis on rare diseases and developing disease awareness and diagnosis programmes with patient organizations. The company has a state-of-the-art manufacturing site for its haematological pipelines in Singapore. On the other hand, ASEAN+ Rare Disease Network has been set up by several rare disease patient groups in ASEAN countries and Hong Kong. You can learn more about these stories in the Features section.

In Spotlights, this issue features Professor Jackie Y. Ying, the Executive Director at Institute of Bioengineering and Nanotechnology (IBN) in Singapore; and Dr Tran Thanh Huong, who shared with us some efforts on cancer control and care carried out in Vietnam. APBN also exclusively interviewed three of the young TR Innovators under 35, gaining more understanding on their bright ideas and innovations.

We hope you learn something new and have a great time reading our magazine.

Thank you.


Carmen, Jia Wen Loh
APBN Editor
You can reach me at jwloh@wspc.com

 

You can always access all APBN's issues on our website: www.asiabiotech.com.
Check us out at Facebook @Asia Pacific Biotech News, Instagram @asiabiotech, or follow us on Twitter @asia_biotech.

 

NEWS CRUNCH  
news Highlights from the E&L China 2020 Conference
news Asia’s ageing population drives development of rehabilitation technologies targeting elderly disabilities
news Virtual Expo Connect to empower access for international pharma to the world’s largest pharma ingredients market
news WEIPU, AstraZeneca, Huadong Medicine, Saint-Gobain, Baxter, Wuxi AppTec, Henlius, Medtronic and more confirmed to speak at E&L China this December
SPOTLIGHT  

MAGAZINE TAGS
About Us
Events
Available issues
Editorial Board
Letters to Editor
Contribute to APBN
Advertise with Us
CONTACT
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Deborah Seah
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   biotech_ad@wspc.com
Copyright© 2021 World Scientific Publishing Co Pte Ltd  •  Privacy Policy